Please login to the form below
escitalopram
This page shows the latest escitalopram news and features for those working in and with pharma, biotech and healthcare.
Lundbeck’s key products shine in Q2 but problems remain
Sales of antidepressant Cipralex (escitalopram) and anti-epileptic Sabril (vigabatrin) also suffered double-digit declines, more than offsetting growth of Lundbeck’s four strategic brands.
Latest news
-
Lundbeck and Otsuka start phase III for Rexulti in bipolar
protection for Abilify and former blockbuster antidepressant Lexapro/Celexa (escitalopram).
-
Surging sales of Lundbeck's CNS drugs assist recovery
Since its former blockbuster Cipralex (escitalopram) started to succumb to generic competition, Lundbeck has looked to two newer antidepressants - Brintellix/Trintellix (vortioxetine) and Rexulti (brexpiprazole) - to step in and fill the
-
Lundbeck to cut 1,000 jobs in major restructure
sales from drugs such as depression treatment Cipralex (escitalopram).
-
US filing aims to elevate Brintellix above its competition
Brintellix has been on the market in the US since 2013 and has been positioned as a successor to its older antidepressant Cipralex (escitalopram), which was selling around $2bn a year
-
Lundbeck and Otsuka's Rexulti set for August launch in US
which it hopes will restore growth after the loss of patent protection on US blockbuster antidepressant Lexapro/Celexa (escitalopram).
More from news
Approximately 2 fully matching, plus 39 partially matching documents found.
Featured jobs
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...
-
Excellent Daily Rate
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Director - Medical Communications - London / South East
-
Excellent Salary and Benefits on offer
Subscribe to our email news alerts
- Planning a pharma exhibition stand? You must read this!
- Leaked no-deal Brexit document forecasts widespread shortages
- AbbVie scores FDA approval for arthritis treatment upadacitinib
- Novo Nordisk shareholder revolt reaches Europe
- BMS buoyed by FDA approval of Celgene’s myelofibrosis drug
- Cello Health Acquire ISS
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Latest intelligence
- The relevance of patient perspectives to value
- Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
- How is the NHS Long-term Plan being put into action?
- Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
- The evolution of real-world studies
- How industry and regulators are using real-world data...
Quick links
Infographics
